Toll-like receptors (TLRs) sense pathogen-associated molecular patterns to activate the production of inflammatory mediators. TLR4 recognizes lipopolysaccharide (LPS) and drives the secretion of inflammatory cytokines, often contributing to sepsis. We report that transient receptor potential melastatin-like 7 (TRPM7), a non-selective but Ca 2+ -conducting ion channel, mediates the cytosolic Ca 2+ elevations essential for LPS-induced macrophage activation. LPS triggered TRPM7-dependent Ca 2+ elevations essential for TLR4 endocytosis and the subsequent activation of the transcription factor IRF3. In a parallel pathway, the Ca 2+ signaling initiated by TRPM7 was also essential for the nuclear translocation of NFkB. Consequently, TRPM7-deficient macrophages exhibited major deficits in the LPS-induced transcriptional programs in that they failed to produce IL-1b and other key pro-inflammatory cytokines. In accord with these defects, mice with myeloid-specific deletion of Trpm7 are protected from LPS-induced peritonitis. Our study highlights the importance of Ca 2+ signaling in macrophage activation and identifies the ion channel TRPM7 as a central component of TLR4 signaling.
INTRODUCTION
Cells of the innate immune system trigger finely tuned cellular responses for host defense while minimizing collateral damage to the host (Iwasaki and Medzhitov, 2015) . An array of patternrecognition receptors (PRRs) sense pathogen-associated molecular patterns (PAMPs) to activate the downstream intracellular signaling machinery necessary for mediating host defense (Brubaker et al., 2015) . A family of membrane-resident PRRs called the Toll-like receptors (TLRs) are of central importance because their ectodomains sense the presence of PAMPs, eliciting cellular responses that fit the pattern of infection (Gay et al., 2014) . According to an emerging framework, the subcellular location of activated TLRs plays a pivotal role in the engagement of specific adaptor proteins, in linked signaling pathways, and in the elaboration of suitable transcriptional programs (Barton and Kagan, 2009; O'Neill and Bowie, 2007) . This paradigm is clearly evident in the case of TLR4, a major sensor of bacterial lipopolysaccharide (LPS) (Poltorak et al., 1998) . Using different adaptors, TLR4 signals distinctly from the cell membrane and early endosomes, expanding the repertoire of transcribed genes and refining the cellular processes for a potent immunological response. LPS triggers dimerization of TLR4 at the cell membrane and promotes the assembly of ''Myddosome,'' the myeloid-differentiation factor 88 (MyD88)-containing adaptor complex, to initiate the activation of NFkB. The interaction of TLR4 with co-receptors, such as CD14 and MD2 (Tan et al., 2015; Zanoni et al., 2011) , also promotes the endocytosis of the LPS-bound TLR4 receptor complex. The formation of TLR4-containing ''signaling endosomes'' triggers the association of TLR4 to TRIF (and its co-adaptor TRAM). Although both MyD88 and TRIF drive the activation and nuclear translocation of NFkB, TRIF uniquely promotes the activation of transcription factor IRF3, resulting in the expression of type I interferon response genes (Kagan et al., 2008) . Thus, TLR4 endocytosis serves as a pivotal regulatory event to amplify NFkB activation and modulate the cellular response through the additional activation of IRF3. The mechanisms that regulate the initiation and rate of TLR4 endocytosis during LPS stimulation are therefore of paramount importance to understanding the full spectrum of TLR4 signaling in inflammatory conditions. In addition to illuminating the underlying role of membrane traffic in inflammatory signaling, defining the mechanisms of TLR4 endocytosis could reveal novel pharmacological targets for the treatment of sepsis.
The LPS-induced endocytosis of TLR4 and the subsequent TRIF-mediated IRF3 activation are highly dependent on CD14, a GPI-linked cell-surface protein. CD14 has been proposed to promote the activation of Syk and phospholipase C g2 (PLC-g2), which are necessary for the Ca 2+ -dependent endocytosis of TLR4 (Chiang et al., 2012; Zanoni et al., 2011) . This model suggested a role for store-operated Ca 2+ entry (SOCE) in the regulation of TLR4 signaling. Similarly, in addition to the essential role in TLR4 endocytosis, intracellular Ca 2+ elevations regulate NFkB activity (Dolmetsch et al., 1997; Nelson et al., 2004) and NLRP3 inflammasome activation (Afonina et al., 2015; Brough et al., 2003) . Interestingly, although the requirement for Ca signaling in inflammatory signaling is abundantly clear, complete loss of SOCE in macrophages deficient in Stim1 and Stim2 does not affect their response to LPS (Vaeth et al., 2015) . This indicates that Orai channels, the molecular conduits of SOCE, are dispensable for LPS-induced cytokine production and NLRP3 inflammasome activation in macrophages. The real identity of the ion channel(s) responsible for LPS-triggered Ca 2+ signaling and TLR4 endocytosis, therefore, emerges as a mystery of biological and pharmacological significance. Transient Receptor Potential (TRP) channels constitute a large family of cation-selective ion channels (Nilius and Szallasi, 2014) . Despite the expression of many TRP channels in hematopoietic cells, their functions in the immune system remain largely undefined. The ''chanzyme'' TRPM7, a TRP channel that also contains an enzymatic kinase domain, is highly expressed in macrophages, but whether it has a role in processes pertinent to innate immunity is not known. TRPM7 is permeable to Na + ,
Ca

2+
, Mg
, and Zn 2+ , and previously, it has been implicated in the endocytosis of Fas receptor (Desai et al., 2012 )-a death receptor that, similar to TLR4, requires the generation of signaling endosomes for full activation during apoptosis. The TRPM7 channel is regulated by various signals pertinent to inflammation, including caspase-dependent cleavage (Desai et al., 2012) and extracellular pH (Jiang et al., 2005) . Furthermore, TRPM7 channel activity is highly sensitive to membrane PIP 2 levels (Langeslag et al., 2007) , which implies regulatory inputs through PLC activation. On the basis of these observations, we hypothesized that TRPM7 could have an important function in macrophage activation by PAMPs. Using a novel Trpm7 fl/fl (LysM Cre) mouse line, wherein TRPM7 is selectively deleted in myeloid cells, including macrophages, we have discovered that LPS-mediated macrophage activation is highly dependent on TRPM7. Mice in which Trpm7 has been deleted selectively in macrophages are resistant to LPS-induced peritonitis. We show that TRPM7 mediates the LPS-induced Ca 2+ elevations that are essential for TLR4 endocytosis (and therefore, IRF3 activation) and for NFkB nuclear translocation. Given that TRP channels are highly attractive drug targets (Moran et al., 2011) , these discoveries could stimulate novel pharmacological strategies for the treatment of chronic infections, septic shock, and autoinflammatory diseases. (LysM Cre) mice in a mixed background of sv129 and C57BL/6J (schematized in Figure 1A ). Through PCR-based genotyping, we confirmed that the LoxP-flanked exon 17 of Trpm7 was deleted in the bone-marrow-derived macrophages (BMDMs) from mouse-derived BMDMs, in which Trpm7 was deleted in thymocytes ( Figure S1A ). The qRT-PCR-based analysis of TRPM7 mRNA expression levels, using exon-17-directed primers, showed substantially decreased amounts of TRPM7 mRNA in Trpm7 À/À BMDMs, relative to WT BMDMs ( Figure S1B ). We also confirmed that the deletion was not detectable in lymphoid cells derived from Trpm7 fl/fl (LysM Cre) mice (data not shown).
RESULTS
Trpm7-Deficient
The deletion of exon 17 generates a frameshift in protein translation, resulting in a null mutant (Jin et al., 2008) . To confirm the loss of TRPM7 channel activity in Trpm7 À/À macrophages, we used whole-cell patch-clamp electrophysiology to record Mg 2+ -inhibitable TRPM7 currents (I TRPM7 ) in Trpm7 +/+ and Trpm7 À/À peritoneal macrophages. The configuration and parameters used for these recordings are shown in Figure S1C .
As shown in the current-voltage relationship ( Figure 1B, (Figure S1D ). The ability of bone marrow cells to differentiate ex vivo into macrophages, in the absence of TRPM7, was also normal in light of the flow-cytometric analysis of differentiated cells. Expression of the characteristic macrophage surface markers CD11b and F4/80 (Geissmann et al., 2010) was comparable between Trpm7 +/+ and Trpm7 À/À BMDMs ( Figure S1E ) when they were immunophenotyped at day 4 (d4) and d7 in culture ( Figure S1F ). The cultured Trpm7 À/À BMDMs did not show any significant deficits in their proliferation ( Figure S1G ).
Collectively, these results demonstrate that Trpm7 is efficiently deleted in macrophages obtained from Trpm7 fl/fl (LysM Cre) mice without any resulting deficits in macrophage development or proliferation. These results, therefore, enable a systematic ''loss of function'' analysis of TRPM7 in macrophage-mediated innate immunity.
TRPM7 is Required for LPS-Induced Inflammatory Gene Expression in Macrophages
Activation of macrophages by PAMPs induces a program of inflammatory gene expression and the eventual secretion of inflammatory cytokines (Medzhitov and Horng, 2009 ). The secretion of potent inflammatory cytokines IL-1b and IL-18, however, also requires additional regulatory inputs from the inflammasome machinery (Garlanda et al., 2013) . The ''activating ligands'' of various inflammasome complexes trigger the caspase-mediated maturation and unconventional secretion of IL-1b and IL-18 (Broz and Dixit, 2016) . Interestingly, both the LPS-induced priming of Il1b and the inflammasome-mediated secretion of IL-1b are dependent on Ca 2+ signaling (Murakami et al., 2012; Rada et al., 2014) , but the identity of the pertinent ion channels is not known. To test the hypothesis that TRPM7 controls inflammasome-dependent IL-1b secretion, we primed Trpm7 +/+ and Trpm7 À/À BMDMs with LPS (100 ng/mL, 3 hr) and then stimulated the BMDMs with various inflammasome activating ligands (Broz and Dixit, 2016; Perregaux and Gabel, 1994 ) (schematized in Figure 1C ). Relative to Trpm7 +/+ BMDMs, Trpm7 À/À BMDMs displayed a drastic reduction ($75% decrease) in IL-1b secretion across all activation conditions ( Figure 1D) . Concomitantly, we also tested the hypothesis that TRPM7 regulates LPSinduced inflammatory gene expression in macrophages. After LPS treatment (100 ng/mL, 3 hr), we observed substantially reduced upregulation of genes involved in the inflammatory response, and reductions in Il1b, Nlrp3, Il6, Tnfa, Nos2, Ccl4 , and Rsad2 were striking ( Figure 1E and Figure S1J ). Treatment of Trpm7 +/+ or Trpm7 À/À macrophages with LPS did not alter Trpm7 mRNA expression ( Figure S1H ), nor did expression of LysM Cre in mixed-background mice with normal Trpm7 alleles (Trpm7 +/+ ) decrease LPS responsiveness in BMDMs ( Figure S1I) .
Next, we reasoned that if TRPM7 was directly regulating TLR4 signaling, then acute siRNA-mediated knockdown of Trpm7 mRNA should also result in a defective LPS response. We successfully knocked down Trpm7 mRNA with siRNA (30 nM) in RAW 264.7 cells, a murine macrophage line ( Figure S2A ). RAW 264.7 cells transfected with anti-TRPM7 siRNA, but not control siRNA, exhibited significant reductions in Nos2, Tnfa, and Il6 mRNA expression after LPS treatment ( Figure S2A ). Similarly, treatment of BMDMs with a potent TRPM7 channel inhibitor, FTY720 (Qin et al., 2013) , reduced LPS-induced expression of Il6 and Il1b mRNA by more than 80% relative to treatment with LPS alone ( Figure S2B ). Interestingly, in RAW 264.7 cells, FTY720 reduced LPS-induced TNFa transcription only modestly ( Figure S2C ), suggesting that TRPM7 might exert additional effects through its kinase domain, independent of I TRPM7 . Use of FTY720 at concentrations sufficient to activate sphingosine-1-phosphate receptors (Brinkmann et al., 2002) did not recapitulate these effects ( Figure S2D ), indicating that FTY720 suppresses the LPS response predominantly through inhibition of the TRPM7 channel.
To examine whether TRPM7 was required for signaling through other TLRs, we stimulated Trpm7 +/+ and Trpm7
BMDMs with LPS (a TLR4 ligand), Pam3CSK4 (a TLR 1/2 ligand), PolyI:C (a TLR3 ligand), and ODN 1826 (a TLR9 ligand, also ''CpG DNA'') ( Figure 1F ). We observed a robust decrease in ligand-induced transcription of Il1b mRNA by LPS and Pam3CSK4 in Trpm7 À/À BMDMs, but not in response to ODN 1826. Moreover, PolyI:C was able to induce robust Rsad2 expression, a measurement of TRIF-dependent signaling, in Trpm7
. As expected, PolyI:C did not induce robust Il1b expression, nor did Pam3CSK4 and ODN 1826 strongly induce Rsad2 mRNA expression (Figure 1F and Figure S1K) . These results indicate that TRPM7 is essential for LPS-induced macrophage activation, but Trpm7 À/À macrophages do not have a general defect in inflammatory signaling. Thus, the drastically reduced expression of Il1b, among many other inflammatory genes, underlies the defect in the secretion of IL-1b in Trpm7 À/À macrophages.
TRPM7 Controls TLR4 Receptor Endocytosis
Internalization of the TLR4-CD14 receptor complex is a pivotal signaling checkpoint during LPS signaling (Rosadini and Kagan, 2017) . Endosomal TLR4-TRIF complexes are necessary for initiating the transcription of IRF3-regulated genes in response to LPS (Kagan et al., 2008) . Moreover, TLR4 association with TRAM-TRIF-dependent signaling amplifies the activation of NFkB upon LPS stimulation (Yamamoto et al., 2003a; Yamamoto et al., 2003b) . Expression of TRIF-dependent gene transcripts (i.e. Ccl4 and Rsad2) was decreased in Trpm7 À/À macrophages ( Figure 1E ). Given that TRPM7 has been previously shown to regulate Fas receptor endocytosis (Desai et al., 2012) , we hypothesized that TRPM7 regulates LPS signal transduction through the control of TLR4 endocytosis. A monoclonal anti-TLR4 antibody (clone: MTS510) binds to TLR4-MD2 dimers only in the absence of LPS-induced assembly of TLR4-signaling complex (which includes dimerization of TLR4-MD2 dimers) (Akashi et al., 2000) . The earliest events in LPS-induced TLR4 signaling can, therefore, be inferred and quantified from the loss of MTS510 signal in flow cytometry. Both Trpm7 +/+ and Trpm7 À/À BMDMs rapidly initiated the assembly of the TLR4 signaling complex after LPS treatment (Figure 2A ), indicating that the initial assembly of the LPS-induced TLR4-signaling complex occurs independently of TRPM7. The monoclonal antibody clone SA15-21 binds to TLR4 regardless of LPS-induced allosteric changes and can be used to track the loss of TLR4 at the cell surface (Akashi et al., 2003) and thus infer and quantify TLR4 endocytosis through flow cytometry. Using this method, we measured the LPS-induced internalization of TLR4 over time. As shown ( Figure 2B ), Trpm7 À/À macrophages showed significantly reduced internalization of TLR4 after LPS stimulation; they displayed nearly 2-fold higher surface TLR4 levels than to Trpm7 +/+ BMDMs (Trpm7 +/+ , 37%; Trpm7 À/À , 66%, n = 4). We then measured the internalization of CD14, which controls LPS-TLR4 endocytosis and formation of LPS-TLR4 signaling endosomes (Zanoni et al., 2011) . After 30 min of LPS treatment, Trpm7 +/+ BMDMs displayed rapid endocytosis of CD14 (37% of CD14 remaining at the cell surface); then CD14 levels recovered over time, presumably due to receptor recycling. In striking contrast, CD14 internalization was severely abated in Trpm7 À/À macrophages (81% of surface CD14
remaining, 30 min after LPS) and there was no observable recovery of surface CD14 levels ( Figure 2C ). Prior to LPS treatment, there were no differences in the total amounts of CD14 or TLR4 at the cell surface in Trpm7 +/+ and Trpm7 À/À BMDMs (Figures S3A and S3B) . These results indicate that TRPM7 is not required for the initial assembly of LPS-TLR4-signaling complex at the plasma membrane but is essential for the endocytosis of the LPS-TLR4-CD14 signaling complex.
LPS-Induced Phosphorylation of NFkB and IRF3 Is
Regulated by TRPM7 LPS-initiated signaling triggers multiple post-translational modifications in the p65 subunit of NFkB (NFkB p65) prior to nuclear translocation (Vallabhapurapu and Karin, 2009 ). The phosphorylation of NFkB p65 at S276 and S536 (in mice, S534) is associated with nuclear translocation (Zhong et al., 1997) and transcriptional transactivation (Yang et al., 2003) , respectively. Likewise, phosphorylation at IRF3 S396 (in mice, S388) is crucial for the induction of Type I IFNs (Lin et al., 1999) . We examined if LPS-induced phosphorylation of either NFkB p65 or IRF3 was impaired in Trpm7 À/À BMDMs. LPS treatment (100 ng/ml) induced the phosphorylation of NFkB p65 in Trpm7 +/+ BMDMs, and this effect was significantly increased compared to Trpm7 À/À BMDMs at both S276 (Trpm7
, 3.4-fold increase) ( Figure S3C ) and at S534 (Trpm7 +/+ , 4.5-fold; Trpm7 À/À 1.8-fold increase).
Similarly, LPS-induced phosphorylation of IRF3 (S388) increased (7.0-fold) after LPS treatment in Trpm7 +/+ BMDMs, relative to 0 min, but Trpm7 À/À BMDMs showed delayed kinetics of phosphorylation and lower levels of P-IRF3 after LPS stimulation in (Figures 2D and 2E and Figure S3D ). We also measured P-IRF3 levels by flow cytometry (using a different anti-P-IRF3 antibody clone validated for flow cytometry). This analysis revealed that LPS treatment for up to 3h did not increase P-IRF3 levels in Trpm7 À/À BMDMs, while it increased P-IRF3 Figures 2D and 2E ). Thus, in the absence of TRPM7, LPS-induced phosphorylation of the key transcription factors, NFkB and IRF3, is significantly compromised.
LPS-Induced Nuclear Translocation of NFkB p65 and IRF3 Is Dependent on TRPM7
Next, we tested whether Trpm7 À/À macrophages are deficient in nuclear translocation of NFkB p65 and IRF3. Deletion of TLR4 signaling adaptors delays the kinetics of NFkB translocation, resulting in reduced cytokine production (Kawai et al., 1999) . Pre-treatment with the dynamin inhibitor Dynasore (80 mM) (Kirchhausen et al., 2008; Macia et al., 2006) inhibits TLR4 endocytosis, and we examined whether this had effects on LPS signaling in Trpm7 +/+ and Trpm7 À/À BMDMs ( Figure S4A Figure 2 . TRPM7 Regulates TLR4 Endocytosis and Downstream NFkB and IRF3 Phosphorylation (A) Flow-cytometry-based quantification of TLR4-MD2 dimers on the BMDM cell surface at indicated times after LPS (1 mg/mL) treatment. The change in the percentage of cell-surface TLR4-MD2 dimers was derived from the staining of cells with an antibody specific for TLR4-MD2 dimers, and calculations were based on the mean fluorescence intensities (MFIs). Error bars represent SEM (n = 3). (B) Flow-cytometry-based quantification of TLR4 on the BMDM cell surface at indicated times after LPS (1 mg/mL) treatment. An anti-TLR4 antibody was used for staining. The error bars represent SEM (n = 4). (C) Flow-cytometry-based quantification of CD14 on the BMDM cell surface at indicated times after LPS (1 mg/mL) treatment with an anti-CD14 antibody. Analysis was similar to panel B. Error bars represent SEM (n = 5). (D) Immunoblot analysis of NFkB p65 phosphorylation at S276 and S534 (in humans S536), P-IRF3 at S388, and IkBa protein levels from whole cells lysates of indicated BMDMs. Cells were stimulated with LPS (100 ng/mL) as indicated. Blots are representative of at least three independent experiments (n > 3). Densitometry values indicate phospho-protein levels relative to total protein, the ratios for which were then normalized to Trpm7 +/+ at 0 min. Grey-dotted line denotes that the bottom gels were obtained from independent samples obtained using identical conditions. (E) Quantification of immunoblots shown in panel D. The densitometric values were calculated from the ratios of phospho-protein levels relative to total protein; these ratios were then normalized to Trpm7 +/+ at 0 min. Bar charts represent means from at least three independent experiments (n = 4 for P-IRF3, n = 3 for others). Error bars are SEM. See also Figure S3D . LPS is dependent on TRPM7. It has been previously established that Dynasore treatment blocks TRIF-dependent signaling through IRF3 (Kagan et al., 2008) . However, in Dynasore-treated WT BMDMs, the nuclear translocation of NFkB p65 and phosphorylation of NFkB p65 are both reduced by $50% after LPS treatment ( Figures S4B and S4C ). We then directly examined the role of TRPM7 in NFkB translocation in response to LPS through ImageStream flow-cytometric imaging, which permits highly quantitative measurements of nuclear localization on large cell populations (Maguire et al., 2011) (Figure 3A) . Indeed, Trpm7 À/À BMDMs exhibit reduced (33% of Trpm7 +/+ BMDMs) nuclear translocation of NFkB p65 30 min after LPS treatment ( Figures 3B and 3C ). We also examined the subcellular distribution of NFkB p65 by using confocal microscopy. Without stimulation, NFkB p65 was diffuse throughout the cytosol in Trpm7 +/+ and Trpm7 À/À BMDMs.
TLR4/MD2 Dimers
Upon LPS treatment (100 ng/mL), nearly 60% of cellular NFkB was localized to the nucleus within 30 min of stimulation in Trpm7 +/+ macrophages. However, NFkB p65 remained diffusely distributed in Trpm7 À/À BMDMs after 30 min of LPS stimulation ( Figure 3D ). The observed differences were not due to expression levels of NFkB p65, which was unaffected (mRNA) by the deletion of TRPM7 ( Figure S4D ). We then examined the subcellular distribution of IRF3 by using confocal microscopy. Similar to NFkB p65, IRF3 was diffuse throughout the cytosol in unstimulated BMDMs. After 30 minutes of LPS treatment (100 ng/mL), low levels of IRF3 were observed in Trpm7 +/+ BMDMs, and nearly 50% of cellular IRF3 was localized to the nucleus within 60 min of stimulation in Trpm7 +/+ macrophages ( Figure 3E ).
However, intensity analysis of IRF3 localization showed that IRF3 remained excluded from the nucleus in Trpm7 À/À BMDMs 60 min after LPS treatment ( Figure 3G and Figure S4G ). To further confirm these findings, we examined total protein distribution by using subcellular fractionation ( Figure S4E ). NFkB p65 was observed in the nuclear fraction within 15 min of LPS stimulation in Trpm7 +/+ BMDMs, with peak translocation at 30 min post-LPS stimulation. However, NFkB p65 translocation was strikingly diminished in Trpm7 À/À BMDMs, with very low levels of nuclear NFkB p65, up to 60 min after LPS treatment ( Figure 3F ). Likewise, IRF3 nuclear translocation was significantly reduced in Trpm7 À/À BMDMs (33% decrease from Trpm7 +/+ by densitometry) after LPS treatment ( Figure S4F ). (legend continued on next page) transcriptional targets of MyD88 and TRIF signaling, respectively ( Figure 4E ). Interestingly, Tnfa and Il6, LPS-induced genes regulated by TRPM7, were not Ca 2+ sensitive ( Figure S5B ). However, (Letari et al., 1991) . On the basis of the use of 100 mM 2-Aminoethoxydiphenylborane (2-APB), it was proposed that the release of Ca 2+ from intracellular stores is necessary for TLR4 endocytosis (Chiang et al., 2012) . However, 2-APB is a highly non-specific ion-channel inhibitor, and it blocks TRPM7 (Li et al., 2006) , amongst many other ion channels (Lemonnier et al., 2004; Maruyama et al., 1997; Prakriya and Lewis, 2001 ] i elevations, regardless of the source, we loaded RAW 264.7 cells with BAPTA-AM and then stimulated them with LPS before measuring TLR4 endocytosis by flow cytometry. BAPTA-AM-loaded cells showed a drastic reduction in TLR4 endocytosis (96% and 86% of surface TLR4 remaining at 30 min and 60 min, respectively), confirming the previous report that Ca 2+ signaling is essential for TLR4 endocytosis ( Figure 4F ).
We also measured TLR4 endocytosis after acutely replacing the extracellular solution with a Ca 2+ -free solution. In this condition, Ca 2+ in the intracellular stores would remain available for mobilization, but there would be no influx of extracellular Ca
2+
. Strikingly, removal of extracellular Ca 2+ also greatly diminished the endocytosis of TLR4, and more than 70% of surface TLR4 remained 60 min after LPS treatment (by contrast, 30% remained in WT) ( Figure 4F ). These results indicate that the influx of extracellular Ca 2+ is essential for TLR4 endocytosis.
LPS-Induced TLR4 Endocytosis Requires Local Elevations in Cytosolic Ca
2+
To further define the control of TLR4 endocytosis by Ca 
LPS-Induced Ca 2+ Entry Is Mediated by TRPM7
The involvement of PLC-g2 for the endocytosis of TLR4 (Chiang et al., 2012; Zanoni et al., 2011) had suggested a Ca 2+ entry mechanism involving SOCE. Surprisingly, the disruption of SOCE by the deletion of Stim1 and Stim2 does not affect TLRligand induced cytokine production in macrophages (Vaeth et al., 2015) . These results indicate that Orai channels, the molecular conduits of SOCE, are not critical for LPS-induced macrophage activation, and the ion channels that mediate LPS-induced Ca 2+ signaling for TLR endocytosis and downstream signaling remain elusive. Considering that TRPM7 is permeable to Ca 2+ and is critical for TLR4 signaling, but not all TLR signaling, we hypothesized that TRPM7 directly mediates LPS-induced Ca 2+ entry. Using BMDMs loaded with Ca 2+ -sensitive ratiometric fluorescent dye Fura-2-AM, we measured [Ca 2+ ] elevations in response to TLR ligands. We observed a robust rise in cytosolic [Ca 2+ ] after stimulation with LPS (100 ng/mL) and Pam3CSK4 (100 ng/mL); LPS yielded a 44.5% larger [Ca 2+ ] elevation than Pam3CSK4 ( Figure 5A ). Stimulation with ODN 1826 (1 mM) also induced [Ca 2+ ] elevations, although to a significantly lower degree than LPS and Pam3CSK4 (down to 29% of LPS and 53% of Pam3CSK4).
To examine the role of TRPM7 in LPS-induced Ca 2+ entry, we performed live-cell imaging Trpm7 +/+ and Trpm7 À/À BMDMs.
Trpm7
+/+ BMDMs display a rapid rise in [Ca 2+ ] i , peaking less than 2 min after LPS stimulation ( Figure 5B ). In contrast, Trpm7 À/À BMDMs displayed a severely blunted rise in LPS-in-
] i , which was decreased in both peak intensity and duration. However, both Trpm7 +/+ and Trpm7 À/À BMDMs responded normally to ionomycin. We made similar observations by using both Fura-2-AM and Fluo-4-AM Ca 2+ imaging dyes (data not shown). We also investigated the [Ca response to both a sustained (15 min) ( Figures 5C-5E ) and a short pulse (60 s) of LPS stimulation, after which the extracellular bath solution was replaced by the LPS-free solution (Figure 5F-H by regulating another channel through its kinase domain. In Figure S2B , we used FTY720, a TRPM7 channel blocker (Qin et al., 2013) , to demonstrate that TRPM7 channel activity played a critical role in LPS-induced gene expression. Here, we demonstrate that FTY720 can block LPS-induced Ca 2+ influx. Treatment of BMDMs with FTY720 (5 mM) decreased LPS-induced Ca 2+ influx 6-fold in comparison to influx in untreated cells ( Figures 6A  and 6B ). In BMDMs, FTY720 (5 mM) also decreased the rate of TLR4 endocytosis ( Figure 6C and Figure S6E ). Nearly 80% of ratio from all samples, and error bars represent SEM. Ionomycin (1 mM) was perfused as a positive control. Results are from n = 3 independent experiments; the n value is indicated in figure. (B) Quantification of peak [Ca 2+ ] i after LPS stimulation from Figure 6A . The box-whisker plot is overlaid on individual measurements. (C) Flow-cytometry-based measurement of cell-surface TLR4 levels in BMDMs, pre-treated with vehicle (DMSO), FTY720, or BAPTA-AM for 15 min, and then stimulated with LPS as indicated. The relative change in the percentage of cell-surface TLR4 levels was inferred on the basis of mean MFI values. Error bars represent SEM (n = 3; * indicates p < 0.05, ** p < 0.01). * indicates significance from WT relative to BAPTA-AM; #, FTY720 group. These results represent typical results obtained in n = 2 independent experiments. (D) Gene expression analysis (qRT-PCR) of human THP-1 monocytes stimulated with LPS (100 ng/mL; 3 hr) with FTY720 pre-treatment as indicated. Bar charts represent means of n = 3 independent experiments. Error bars represent SEM (n = 3). Table S1 . Error bars represent SEM (n > 5).
(legend continued on next page) surface TLR4 remained 60 min after LPS treatment, and BAPTA-AM pre-treatment completely ablated TLR4 endocytosis. FTY720 treatment also mimicked the effects of BAPTA-AM on the phosphorylation of NFkB p65 ( Figure S6A and S6B) . Both FTY720 and BAPTA-AM decreased the phosphorylation of NFkB (S534) to $50% of untreated cells. We also examined RAW 264.7 cells, a murine BALB/c macrophage cell line, in response to TRPM7 blockade by FTY720. In these cells, FTY720 treatment decreased LPS-induced Ca 2+ influx to $45% of that in untreated cells ( Figure S6C and S6D) . FTY720 also drastically reduced the phosphorylation of NFkB p65 at S534 ( Figure S6F) . Transcriptionally, the reduction in LPSinduced Il1b mRNA by FTY720 was comparable to amounts resulting from the clamping of [Ca 2+ ] i with BAPTA-AM ( Figure S6G ). Using cell fractionation, we determined that the nuclear translocation of NFkB p65 is greatly delayed in FTY720-treated RAW 264.7 cells, 15 min after LPS treatment ( Figure S6H ). Some translocation was detectable at 30 min, but it was significantly less than that in vehicle-treated controls. The inhibition of NFkB p65 nuclear translocation by FTY720 was also evident from immunofluorescence confocal microscopy ( Figure S6I ) and ImageStream flow cytometry (data not shown). Furthermore, we tested the effect of FTY720 on LPS-induced transcription in human THP-1 monocytes. In response to LPS, FTY720 (5 mM) pre-treatment decreased the transcription of both CCL4 (to 51% of untreated), IL6 (to 14% of untreated), and IL1B (to 16% of untreated) ( Figure 6D ), suggesting that both MyD88-and TRIF-dependent signaling are compromised in human monocytes. Thus, blocking TRPM7 channel activity acutely inhibits LPS-induced Ca 2+ entry, TLR4 endocytosis, and gene transcription, similar to results for Trpm7 À/À macrophages. Together, these results indicate that the TRPM7 channel directly conducts Ca 2+ to mediate LPS-induced signaling.
CD14, Not TLR4, Mediates LPS-Induced Ca 2+ Entry in
Primary Macrophages
Given that the TRPM7 channel mediates LPS-induced Ca 2+ entry, the molecular identity of the LPS receptor responsible for modulating TRPM7, and thereby Ca 2+ entry, is unknown.
To address this question, we performed live-cell Ca 2+ imaging on BMDMs from C57BL/6J (herein, ''WT''), Tlr4 ] i in response to LPS (down to $15% of WT) ( Figure 6F ). Thus, these results indicate that CD14 functions as the predominant trigger for LPS-induced Ca 2+ influx. 
Peritonitis
We evaluated the significance of macrophage-resident TRPM7 in vivo by challenging the mice with an intraperitoneal injection of LPS (0.2 mg/kg) ( Figure 7A ). In vivo administration of LPS elicits a rapid cytokine response, and the increased serum levels of TNFa, IFN-g, and IL-6 promote pathological inflammation in less than 6 hr after LPS administration (Rittirsch et al., 2008) . After LPS challenge, mice were observed for pathological symptoms with the use of a composite clinical score (Kadl et al., 2007) (Table S1 ), recorded in a double-blinded manner. Figure S7 and Table S1 .
DISCUSSION
We have uncovered a novel TRPM7-mediated Ca 2+ -signaling pathway that is essential for LPS-induced macrophage activation and is, therefore, central to innate immunity. The TRPM7 channel mediates cytosolic Ca 2+ elevations in response to LPS, and this Ca 2+ influx is necessary for TLR4 receptor endocytosis and IRF3 activation. Similarly, in a presumably parallel arm of LPS signaling, the Ca 2+ influx also regulates the activation and nuclear translocation of NFkB. Thus, TRPM7 controls the transcriptional programs mediated by the two key transcription factors, NFkB and IRF3, during LPS-induced macrophage activation. In accordance with these findings, the selective deletion of Trpm7 in myeloid cells renders the mice resistant to LPS-induced peritonitis, revealing TRPM7 as a major controller of pro-inflammatory cytokine production by myeloid cells in vivo. These discoveries are highly significant because TRPM7 now emerges as a pharmacologically tractable molecular target for developing novel therapeutic strategies directed against sepsis and auto-inflammatory diseases. LPS has long been known to trigger a rapid elevation in cytosolic Ca 2+ (Letari et al., 1991) , but the identity of the ion channel responsible for initiating this Ca
2+
-signaling pathway has remained elusive. Likewise, the endocytosis of the TLR4 signaling complex is a crucial early event in cellular LPS response, and this process was known to be Ca 2+ dependent (Chiang et al., 2012) . However, because of the non-specific properties of pharmacological inhibitors, it was previously concluded that the release of Ca 2+ from intracellular stores and through IP3 receptors is the key process necessary for TLR4 endocytosis. In that model, the activation of PLCg2 (and the generation of IP3) during LPS signaling leads to the release of Ca 2+ from the endoplasmic reticulum through the IP3 receptors and subsequently results in SOCE through the Orai channels. Surprisingly, macrophages that are completely deficient in Stim1-Stim2 and SOCE show no defects in LPSinduced production of inflammatory cytokines, indicating that SOCE is not a major determinant of TLR4 signaling (Vaeth et al., 2015) . The release of intracellular Ca 2+ (and subsequent SOCE) might occur concomitantly with TRPM7 activity, but these processes are not the salient regulators of TLR4 signaling. This is also supported by the observation that although Ca 2+ elevations are severely diminished in Trpm7 À/À macrophages, they are not entirely absent. We emphasize that our findings do not negate a role for other ion channels in regulating various aspects of macrophage activation (Desai and Leitinger, 2014; Feske et al., 2015; Santoni et al., 2013; Tauseef et al., 2012; Yamamoto et al., 2008) . Although pharmacological approaches have suggested a vague role for TRPM7 in macrophages (Schilling et al., 2014) , our study is the first to define the function of TRPM7 in a mechanistic manner by using mice with a targeted genetic deletion of TRPM7 in macrophages. Given our observations that CD14, not TLR4, is vital to LPSinduced Ca 2+ entry, we propose that the activation of TRPM7 This study defines the function of TRPM7 channel activity in macrophage activation, but the role of the TRPM7 kinase activity in inflammatory signaling remains unexplored. Our experiments with the TRPM7 channel blocker FTY720 reveal that TRPM7 channel activity does not account for the entire spectrum of defects seen in Trpm7 À/À macrophages. In the embryonic stem cells, the cleaved TRPM7 kinase domain has been shown to translocate to the nucleus and modify the chromatin landscape through the phosphorylation of histones (Krapivinsky et al., 2014) . Given that TRPM7 is cleaved by multiple proteases (including caspases), a similar function of the cleaved kinase domain could be of salience to inflammatory gene expression in macrophages. In addition to the role of the kinase domain, a number of other important questions emerge from this study and are the focus of our ongoing and future studies. The molecular mechanism by which TRPM7 is activated during LPS signaling is not yet clear. Previously, we have shown that the TRPM7 channel is activated by a caspase-mediated proteolytic event that also dissociates the kinase domain from the membrane-resident channel (Desai et al., 2012) . The function of TRPM7 kinase activity in the regulation of inflammatory gene expression is thus a major topic of interest. Intracellular LPS has been shown to activate caspase-11 (Shi et al., 2014) , but LPS-induced, TRPM7-mediated Ca 2+ influx is very rapid, and it is highly unlikely that a brief pulse of LPS can activate caspase-11 in less than a minute. Other possibilities include direct activation of TRPM7 by LPS or activation by the local depletion of PIP2 (Langeslag et al., 2007) in close proximity to TLR4.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
Protein Immunoblots
Biochemical fractions were prepared with modification as described by Rockland, Inc. (http://www.rockland-inc.com/ NuclearExtract.aspx). In brief, macrophages (5 3 10 6 cells) were treated as indicated and collected at 4 C. Cells were washed with 1 mL of cold PBS and resuspended in 6X pellet volumes (PV) of cytoplasmic buffer ([in mM] 10 HEPES, 60 KCl, 1 EDTA, and 0.075% NP40) for 5 min on ice. The suspension was centrifuged for 5 min at 1500 rpm at 4 C. Supernatant (cytoplasmic extract) was removed to a new tube. Pellet was washed in 12X PV in cytoplasmic buffer without NP40. Nuclei were collected by centrifugation and supernatants were discarded. The pellet was lysed in 1X PV with nuclear buffer ([in mM] 20 Tris-Cl, 420 NaCl, 1.5 MgCl 2 , 0.2 EDTA) for 10 min on ice. Both cytoplasmic extracts and nuclei mixture were centrifuged at maximum speed for 10 min to remove debris. Supernatants were collected for immunoblot analysis.
Whole cell lysates were prepared by collecting cells in Lysis Buffer (150 NaCl, 50 Tris-HCl pH 7.4, 2 EDTA, 0.5% Triton X-100) and lysis cells for 30 min on ice. Lysates were cleared of debris by centrifugation at 14000rpm for 10 min. Supernatants were collected, mixed with 5X Laemmli Sample Buffer (0.3M Tris-HCl pH 6.8, 10% SDS, 50% glycerol, 25% beta-mercaptoethanol, 0.05% bromophenol blue), and boiled at 95 C prior to SDS-PAGE analysis. Using cleared lysates, protein content was determined via BCA Assay (ThermoFisher; #23225) according to the manufacturer's instructions. Samples were loaded into 4%-20% or 12% ExpressPlus PAGE gels (GenScript; #M42012 and #M01210, respectively) and electrophoretically separated according to the manufacturer's instructions (150 V for 60 min in MES Running Buffer).
Immunofluorescence Microscopy
BMDMs were seeded on plates seeded with coverslips overnights. BMDMs were then treated as indicated at 37 C. Cells were washed in cold PBS and fixed in cold PFA (4% PFA in PBS) for 15 min at RT. Coverslips were washed 3 times with wash buffer (0.05% tween-20 in PBS) to removed residual PFA. Coverslips were permeabilized for 5 min in 0.1% Triton X-100 in PBS and blocked for 1h at RT in blocking buffer (1% BSA, 0.1% fish gelatin, 0.1% Triton X-100, 0.05% Tween-20, and 5% donkey serum in PBS). Coverslips were stained with the anti-NFkB or anti-IRF3 antibody (1:250 dilution in blocking buffer) (Cell Signaling; #4764 and #4302), respectively) for 2h at RT. Cells were washed 3X with wash buffer and stained with anti-rabbit-Alexa Fluor 488 conjugated antibody (1 mg/mL) (JacksonImmuno) for 1h at RT. After washing 3X in wash buffer, coverslips were stained with Hoechst 33342 (1:2000) for 10 min at RT. Coverslips were washed 2X in wash buffer prior to mounting with VectaMount medium (Vector Laboratories; #H5000). Mounted samples were cured overnight at RT and imaged within 24h. Images were collected using an Olympus FluoView 1000 under 40X or 60X objective lens. Images were analyzed with ImageJ software.
Nuclear Translocation via ImageStream
Cells were treated as described at 37 C. Cells were then transferred to 4 C for 5 min, washed 2X with PBS, and collected by gentle scraping. Cells were fixed with cold paraformaldehyde (4%) for 15 min at RT. Cells were permeablized with Perm Buffer (2 mM EDTA, 0.5% BSA, 0.1% Triton X-100 in PBS) for 5 min and stained with primary antibody and anti-rabbit secondary antibody as recommended in Perm Buffer. Cells were resuspended in FACS Buffer (2 mM EDTA, 0.5% BSA in PBS) with DRAQ5 prior to analysis via ImageStream.
Ca
2+ Imaging
Cells were allowed to adhere to #1 thickness coverslips overnight ($16h) prior to analysis. For ratiometric Ca 2+ imaging, cell were incubated for 30 min with agitation at RT with 5 mM of Fura-2-AM in presence of 0.02% of pluronic acid (BIOTIUM) and 500 mM probenecid (Enzo; ALX-430113G005) in Ringer solution ([in mM] 155 NaCl, 4.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 5 HEPES, 10 glucose, pH 7.4). Fura-2-AM emissions were collected at 510 nm and with 340/380 nm excitation. Ratio of 340/380 was calculated by the DF/F 0 method (Helmchen, 2011) . For Fluo-4-AM imaging, cells were incubated for 2h at 37 C with 5 mM of Fluo-4-AM in presence of 0.02% of pluronic acid and 2.5 mM probenecid in standard extracellular solution (SES; [in mM] 145 NaCl, 5 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 HEPES, 10 glucose, pH 7.4). For Fluo-4 imaging, cells were excited at 488 nm and emissions were measured at 530 nm. In all cases, fluorescent excitation was performed using a DG4 Illuminator (Sutter Instruments) and fluorescence was detected using an ORCA-Flash 4.0 V2 CMOS camera (Hamamatsu) using SlideBook 6 software. Measurements were performed with continuous perfusion of bath solution with a gravity feed system and ionomycin (1 mM) was perfused as a positive control for cellular responsiveness. Experiments were performed in Ringer solution or SES with addition of TLR ligands as indicated in figures and legends. Trpm7 fl/fl and Trpm7 fl/fl (LysM Cre) mice were injected intraperitoneally with 0.2 mg/kg LPS (200ml) or PBS. Mice were weighed less than 1 hr prior to injection to determine dosage. Mice were randomly assigned to treatment groups and all observations were performed by a double-blinded experimenter (blind to treatment and genotype). Mice were observed for up to 24h. Mice were euthanized at 4 hours to collect blood serum and peritoneal immune cells. Serum was collected after centrifugation of whole blood at 4 C for 10 min at 2500g. Serum concentrations of IL-6 and TNFa were measured via ELISA (Biolegend). IFNg was measured via Luminex analysis conducted by the UVA Flow Cytometry Core Facility.
In vivo LPS Challenge
Peritoneal cells were isolated by injection of 8 mL of cold PBS into the peritoneal cavity. The peritoneal lavage fluid was collected, and cells were centrifuged at 4 C for 6 min at 350 g. The pellet was resuspended in ACK lysis buffer for 5 min to lyse red blood cells. Cells were collected and subjected to staining for flow cytometry. Cells were stained on ice with TruStain FcX (Biolegend, #101320) for 10 min and then for 30 min with anti-F4/80 (clone: BM8), CD11b (clone: M1/70), and CD45 (clone: 30-F11) antibodies at the manufacturer recommended concentrations. Stained cells were washed with 1 mL of cold FACS Buffer, resuspended in 200 mL of FACS Buffer, and placed on ice for immediate analysis. Cell surface staining was measured on the BD FACSCanto II. Gating strategy is described in Figure S7 .
Statistics
All data were analyzed using Origin Pro 9.1.0 (Origin Lab) or Excel (Microsoft) software. Data are presented as means with error bars, which reflect standard deviation (SD) or standard error of the mean (SEM) as indicated in figure legends. Bar charts were plotted with Excel, dot plots and box charts were plotted using Origin Pro, and Violin plots were plotted in R studio (R package 'ggplot2 0 ). Statistical box charts are shown as a box (range of 25-75 percentile) and whisker bars (1-99 percentile) with data points overlaid; the median is represented by a horizontal line and mean is shown as an empty square. Violin plots represent distribution of individual sample values and the diamond represents the mean value for the group. Normality and variance for datasets were tested graphically. The sample size is indicated in figures and legends. Statistical significance was determined using paired t test (two-tailed), unless indicated otherwise in legend. A p value less than 0.05 was considered statistically significant.
